Our CEO, Andreas Raabe, recently discussed our company’s growth and strategic goals in an interview with Outsourcing Pharma. He outlines how we differentiate ourselves from competitors and provide value to our customers.
Find the complete article below.
In conversation with Andreas Raabe
Andreas Raabe, our CEO recently spoke with Outsourcing Pharma about his ambitions for Adragos Pharma and the value we provide to our customers.
In the interview Raabe shares details of our recent growth trajectory which underscores our commitment to expanding our production footprint in key markets across Europe, Japan, and North America. He also discusses our plans to double or triple the size of the business over the coming years through strategic acquisition and organic expansion.
Raabe also talks about our integrated approach, offering both development and manufacturing services to enhance operational efficiencies for customers. He also highlights three key areas that set Adragos apart from its competitors:
● Leveraging cutting-edge technology
● Focusing on innovative molecules
● A commitment to operational excellence
Finally, Raabe details our commitment to ESG, sharing some of the initiatives we’ve been working on to reduce our carbon emissions. Read the article in full here.
